Newsletter | July 9, 2025

07.09.25 -- Billions Of Dollars In CDMO Secondary Packaging Of Biologics

SPONSOR

20-minute capacity and capabilities quick-looks, 20+ brand new CDMO presenters to evaluate for best-fit this quarter – and a (virtual) commitment of less than 20 percent of your day? We're confident you don’t need 20/20 vision to see the value in this! Join us for Outsourced Pharma's July Partner Week – including sessions in Small Molecule API/HPAPI, Small Molecule Finished Dosage Form, ADC, Analytical Services, and Fill/Finish among others. Registration, on-demand access, and interactive Q&A are free.

INDUSTRY INSIGHTS

Embrace Quality Risk Management To Build A Strong Quality Culture

Using QRM gives a company the ability to maintain compliance while also identifying product issues that could be harmful to the consumers, some being susceptible patients.

Continuous Flow Techniques For Fine Chemical Manufacturing

Explore the advantages and challenges of continuous flow processes and the concept of mini-monoplant technology, along with examples that demonstrate the versatility of continuous processing.

Bend Successfully Rescues Powder-Filled Capsule Program

Learn how to overcome tech transfer challenges and ensure consistent content uniformity by leveraging multidisciplinary expertise and decades of commercial encapsulation experience.

FEATURED EDITORIAL

Billions Of Dollars In CDMO Secondary Packaging Of Biologics

Chief Editor Louis Garguilo analyzes a report projecting the biologics CDMO secondary packaging market could rise from $2.59 billion this year to USD $5.50 billion by 2034. Projecting so far into the future is tricky business, but Garguilo explains the ultimate value.

The Matryoshka Model: The New Face Of Contract Packaging In Pharma

Contract packaging organizations are the outer layer of the pharmaceutical Matryoshka (the iconic Russian nesting doll): the final form that contains within it a series of intricately crafted parts.

INDUSTRY INSIGHTS CONTINUED

Formulation Scientist Shares What Drug Development Teams Should Never Do

Learn why transportation testing is critical to drug development — and how proactive planning can protect your product and investment from costly setbacks.

Smart Softgels: Driving Innovation In Pharma

Learn about how softgels are poised to facilitate innovation in the pharmaceutical industry as well as ongoing advancements in optimizing drug bioavailability through nano formulations.

How To Optimize Labeling In A Pharmaceutical Environment

Accurate, readable pharmaceutical labels are crucial. Learn to navigate considerations like printing, application tolerances, and inspection to select the right machinery for your production environment.

SOLUTIONS

Controlled Expansion Of Supercritical Solutions (CESS®) Technology

Nanoform’s award-winning CESS® technology uses bottom-up nanoparticle engineering to create API nanoparticles, enhancing the therapeutic potential of small molecule drugs.

Cambrex Scientist Spotlight: Myoung Goo Kim

Myoung Goo Kim, Chemistry R&D Manager in High Point, NC, is a recognized expert in process chemistry, specializing in API manufacturing for Cambrex’s clients.

Medicinal Chemistry - India

Pharma Expanse supports NCE programs from discovery to commercialization across 9 sites in 5 countries—offering a cost-neutral, innovative business model.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: